You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

busulfan

Showing 1 - 25 of 361
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • Busulfan
  • Flu/Cy/ATG or Cy/ATG
  • (no location specified)
Oct 1, 2023

Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

Recruiting
  • Leukemia, Acute Lymphoblastic
  • +5 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Jul 19, 2022

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

Not yet recruiting
  • Acute Myeloid Leukemia in Remission
  • Nantes, Loire Atlantique, France
  • +22 more
Jun 15, 2023

Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Pediatric Cancer
  • Boston, Massachusetts
  • +1 more
Oct 24, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

Recruiting
  • Chronic Granulomatous Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 23, 2022

Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Busulfan test dose
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)

Recruiting
  • T-cell Non-Hodgkin Lymphoma
  • Lymphoma, Extranodal NK-T-Cell
  • Busan, Korea, Republic of
  • +1 more
Aug 17, 2022

Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)

Not yet recruiting
  • Thrombotic Disorder
  • (no location specified)
Jun 8, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Busulfan
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022

Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,

Recruiting
  • Immunodeficiency
  • Hematopoietic Stem Cell Transplantation
  • Post-Transplant Cyclophosphamide (PTCY)
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • busulfan
  • +7 more
  • (no location specified)
Feb 17, 2022

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

Completed
Has Results
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 18, 2021

Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

Active, not recruiting
  • Chronic Granulomatous Disease Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 11, 2022

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Myeloid Hematological Malignancies
  • Busulfan
  • +3 more
  • Houston, Texas
    Texas Children's Hospital
May 13, 2022

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Busulfan
  • +3 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023